Australia markets close in 4 hours 24 minutes

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.75+0.49 (+3.70%)
At close: 04:00PM EDT
Show:
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
301,940
292,567
353,314
41,333
37,977
Cost of revenue
121,726
118,814
90,565
415
180,238
Gross profit
180,214
173,753
262,749
40,918
-142,261
Operating expenses
Research development
605,929
588,453
604,081
561,423
438,215
Selling general and administrative
585,414
631,866
488,026
67,881
78,001
Total operating expenses
1,195,117
1,223,950
1,091,505
628,860
515,586
Operating income or loss
-1,014,903
-1,050,197
-828,756
-587,942
-657,847
Interest expense
20,180
4,091
2,895
3,205
15,080
Total other income/expenses net
83,901
30,777
-4,068
9,242
1,313,692
Income before tax
-954,610
-1,026,940
-839,653
-576,677
625,056
Income tax expense
2,381
-8,791
7,076
-5,136
43,774
Income from continuing operations
-956,991
-1,018,149
-846,729
-571,541
581,282
Net income
-998,810
-1,018,149
-846,729
-571,541
581,282
Net income available to common shareholders
-998,810
-1,018,149
-846,729
-571,541
581,282
Basic EPS
-
-23.75
-22.07
-16.91
18.94
Diluted EPS
-
-23.75
-22.07
-16.91
18.94
Basic average shares
-
42,869
38,370
33,802
30,691
Diluted average shares
-
42,869
38,370
33,802
30,696
EBITDA
-
-982,600
-794,066
-559,790
644,644